Why Big Pharma is Betting Big on the US Fill Finish Manufacturing Market
In a post-pandemic world where vaccine development, biologics, and advanced therapies are racing ahead, one critical process has emerged as a quiet giant: fill finish manufacturing. This final step in drug production — where biologics and pharmaceuticals are filled into vials or syringes and sealed — is now commanding serious attention in the U.S. life sciences sector....
0 Comments
0 Shares